Embecta Corp.
EMBC · NASDAQ
Market closed$3.44$0.190000 (+5.85%)After hours $3.44 · 0.00%
Key statistics
Previous close$3.25
Open$3.28
Day high$3.45
Day low$3.28
52-week high$15.55
52-week low$2.77
Market cap204.09M
Volume1.33M
Average volume2.54M
P/E ratio1.32
Forward P/E—
EPS2.60
Dividend yield+13.37%
Market context
Why it moved
EMBC shares declined further as multiple securities class action lawsuits filed against Embecta Corp. continued to weigh on investor sentiment, following the company's disastrous Q2 2026 earnings report that revealed a sharp revenue miss, a roughly 61% drop in adjusted EPS, a massive guidance cut, and a 93% dividend reduction tied to significant weakness in its pen needle business.
What is happening
Recent company-specific developments and publisher coverage.
PR Newswire · July 16, 2026EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff Deadline in Embecta Corp. Securities Class Action - Contact SueWallStMassDevice · June 20, 2026Embecta names new SVP and president, North AmericaStock Titan · May 8, 2026Investors can hear embecta management at BofA conference on May 13Stock Titan · May 5, 2026Embecta posts fiscal Q2 results, investor webcast starts at 8 a.m. ET Benzinga · May 18, 2026B of A Securities Maintains Underperform on Embecta, Lowers Price Target to $3 Mt Newswire · May 18, 2026BofA Securities Adjusts Price Target on Embecta to $3 From $11 Mt Newswire · May 15, 2026Embecta Closes Acquisition of Owen Mumford Benzinga · May 5, 2026Embecta Lowers FY2026 Adj EPS Guidance from $2.80-$3.00 to $1.55-$1.75 vs $2.81 Est; Lowers FY2026 Sales Guidance from $1.071B-$1.093B to $1.015B-$1.035B vs $1.071B Est Benzinga · May 5, 2026Embecta Q2 Adj. EPS $0.27 Misses $0.42 Estimate, Sales $221.800M Miss $235.567M Estimate Benzinga · March 19, 2026Embecta Rallies After UK Firm Deal Worth $200 Million Mt Newswire · March 19, 2026Embecta to Acquire Owen Mumford Benzinga · March 19, 2026Embecta Agrees To Acquire Owen Mumford For £150M